Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -1.20M | -1.03M | -1.73M | -928.80K | -931.80K |
Total Depreciation and Amortization | 2.50K | 3.10K | 3.10K | 3.10K | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 16.50K | -2.90K | 0.00 | 0.00 | 1.30K |
Change in Net Operating Assets | -99.90K | -609.00K | 810.10K | -420.80K | 198.70K |
Cash from Operations | -1.29M | -1.64M | -917.40K | -1.35M | -731.80K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 388.10K | 871.40K | -37.70K | -40.40K | 954.30K |
Cash from Investing | 388.10K | 871.40K | -37.70K | -40.40K | 954.30K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 2.09M | -- | 0.00 | 1.74M | 1.67M |
Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -57.70K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 2.09M | -- | 0.00 | 1.74M | 1.62M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1.20M | -768.90K | -955.10K | 354.60K | 1.84M |